Literature DB >> 15857182

The 35delG mutation in the connexin 26 gene (GJB2) associated with congenital deafness: European carrier frequencies and evidence for its origin in ancient Greece.

Gérard Lucotte1, Florent Diéterlen.   

Abstract

The 35delG mutation in the connexin 26 gene (GJB2) at the DFNB1 locus represents the most common mutation in Caucasian patients with genetic sensorineural deafness. This new meta-analysis concerns published carrier frequencies of the 35delG mutation in 27 populations for 6,628 unrelated individuals in Europe and in the Middle East; the mean carrier frequency of the mutation is 1.9%. Compared on a regional basis, the most elevated carrier frequency value is of 1 individual carrier in 31 in southern Europe. It is probable that the 35delG mutation originated in ancient Greece and was subsequently propagated in other Mediterranean countries (especially in Italy) during recent historical times.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15857182     DOI: 10.1089/gte.2005.9.20

Source DB:  PubMed          Journal:  Genet Test        ISSN: 1090-6576


  17 in total

1.  A recessive Mendelian model to predict carrier probabilities of DFNB1 for nonsyndromic deafness.

Authors:  Juan R González; Wenyi Wang; Ester Ballana; Xavier Estivill
Journal:  Hum Mutat       Date:  2006-11       Impact factor: 4.878

2.  Does epidermal thickening explain GJB2 high carrier frequency and heterozygote advantage?

Authors:  Pio D'Adamo; Veronica Ileana Guerci; Antonella Fabretto; Flavio Faletra; Domenico Leonardo Grasso; Luca Ronfani; Marcella Montico; Marcello Morgutti; PierPaolo Guastalla; Paolo Gasparini
Journal:  Eur J Hum Genet       Date:  2008-12-03       Impact factor: 4.246

Review 3.  The Genetic Basis of Nonsyndromic Hearing Loss in Indian and Pakistani Populations.

Authors:  Denise Yan; Abhiraami Kannan-Sundhari; Subramanian Vishwanath; Jie Qing; Rahul Mittal; Mohan Kameswaran; Xue Zhong Liu
Journal:  Genet Test Mol Biomarkers       Date:  2015-07-17

4.  Spectrum of GJB2 mutations in Cypriot nonsyndromic hearing loss subjects.

Authors:  Vassos Neocleous; Constantina Costi; Christos Shammas; Elena Spanou; Violetta Anastasiadou; George A Tanteles; Leonidas A Phylactou
Journal:  J Genet       Date:  2014-08       Impact factor: 1.166

5.  Did the GJB2 35delG mutation originate in Iran?

Authors:  Vahideh Norouzi; Hiva Azizi; Zohreh Fattahi; Fatemehsadat Esteghamat; Niloofar Bazazzadegan; Carla Nishimura; Nooshin Nikzat; Khadijeh Jalalvand; Kimia Kahrizi; Richard J H Smith; Hossein Najmabadi
Journal:  Am J Med Genet A       Date:  2011-09-09       Impact factor: 2.802

6.  Carrier frequency of GJB2 (connexin-26) mutations causing inherited deafness in the Korean population.

Authors:  Sung-Hee Han; Hong-Joon Park; Eun-Joo Kang; Jae-Song Ryu; Anna Lee; Young-Ho Yang; Kyoung-Ryul Lee
Journal:  J Hum Genet       Date:  2008-12-02       Impact factor: 3.172

Review 7.  Gene therapy for the inner ear: challenges and promises.

Authors:  Allen F Ryan; Stefan Dazert
Journal:  Adv Otorhinolaryngol       Date:  2009-06-02

8.  Prevalence of DFNB1 mutations among cochlear implant users in Slovakia and its clinical implications.

Authors:  L Varga; I Mašindová; M Hučková; Z Kabátová; D Gašperíková; I Klimeš; M Profant
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-05-23       Impact factor: 2.503

9.  GJB2 Mutation Spectrum and Genotype-Phenotype Correlation in 1067 Han Chinese Subjects with Non-Syndromic Hearing Loss.

Authors:  Jing Zheng; Zhengbiao Ying; Zhaoyang Cai; Dongmei Sun; Zheyun He; Yinglong Gao; Ting Zhang; Yi Zhu; Ye Chen; Min-Xin Guan
Journal:  PLoS One       Date:  2015-06-04       Impact factor: 3.240

10.  Spectrum of genetic changes in patients with non-syndromic hearing impairment and extremely high carrier frequency of 35delG GJB2 mutation in Belarus.

Authors:  Nina Danilenko; Elena Merkulava; Marina Siniauskaya; Olga Olejnik; Anastasia Levaya-Smaliak; Alena Kushniarevich; Andrey Shymkevich; Oleg Davydenko
Journal:  PLoS One       Date:  2012-05-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.